Literatura médica e a ética em pesquisa: desafios para a prevenção quaternária

Hamilton Lima Wagner; Cynthia Ramos Soares; João Victor Moreira

doi:10.5712/rbmfc10(35)1116

Authors

Hamilton Lima Wagner Prefeitura Municipal de Curitiba, Paraná,
Cynthia Ramos Soares Secretaria Municipal de Saúde. Curitiba, PR,
João Victor Moreira Secretaria Municipal de Saúde. Curitiba, PR,

DOI:

https://doi.org/10.5712/rbmfc10(35)1116

Keywords:

Quaternary Prevention, Biomedical Research Ethics, Conflict of Interest

Abstract

This article discusses the quality of scientific evidence published in the medical field. Currently, there is a difficulty in assessing the quality of these publications, since large clinical trials are sponsored by the health industry, particularly the pharmaceutical industry, which requires confidentiality clause of the raw data obtained in the research. This creates significant implications for both the practice of health professionals and the production of health care guidelines. Given these uncertainties of health information, quaternary prevention emerges as a proposal to strengthen doctor-patient relationship as space for preventive activities and other health actions.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biography

Hamilton Lima Wagner, Prefeitura Municipal de Curitiba, Paraná,

Possui graduação em Medicina pela Universidade Federal do Rio Grande do Sul(1980), especialização em Saúde Coletiva - Gerencia de Unidades de Saúde pela Pontifícia Universidade Católica do Paraná(1996), especialização em Saúde Coletiva - Enfase em Saúde da Família pela Universidade Federal do Paraná(1998), especialização em Medicina de Família pela Faculdade Evangélica do Paraná(2003), mestrado em Princípios da Cirurgia pela Faculdade Evangélica do Paraná(2003) e residencia-medicapela Hospital de Clínicas de Porto Alegre(1982). Atualmente é Membro de corpo editorial da Revista de APS e Membro de corpo editorial da Revista Brasileira de Medicina de Família e Comunidade. Currículo Lattes: http://lattes.cnpq.br/9237492571873063

References

Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. New York: Churchill Livingstone; 1997.

Moynihan R, Doran E, Henry D. Disease mongering is now part of the global health debate. PLoS Med. 2008;5(5):e106. http://dx.doi.org/10.1371/journal.pmed.0050106. PMid:18507498. DOI: https://doi.org/10.1371/journal.pmed.0050106

Gøtzsche PC. Deadly medicines and organised crime: how big pharma has corrupted healthcare. Cornwall: Radcliffe Publishing; 2013.

Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trial and selective publication. J Eval Clin Pract. 2014;20:908–914. DOI: https://doi.org/10.1111/jep.12147

Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014; 348:g3725. http://dx.doi.org/10.1136/bmj.g3725. PMid:24927763. DOI: https://doi.org/10.1136/bmj.g3725

Akst J. Dealing with irreproducibility. The Scientist: Exploring Life, Inspiring Innovation [Internet]. 2014. [acesso em 2015 Oct 18] Disponível em: http://www.the-scientist.com/?articles.view/articleNo/39654/title/Dealing-with-Irreproducibility/

Brynner R, Stephens T. Dark remedy: the impact of thalidomide and its revival as a vital medicine. New York: Perseus Publishing; 2001.

Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Amer J of Psychiatry. 2006(163):185-194. DOI: https://doi.org/10.1176/appi.ajp.163.2.185

Fletcher RH, Fletcher S. Epidemiologia clínica. Porto Alegre: Artmed; 2006.

Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124. http://dx.doi.org/10.1371/journal.pmed.0020124. DOI: https://doi.org/10.1371/journal.pmed.0020124

Senn S. Three things that every medical writer should know about statistics. The Write Stuff. 2009; 18(3):159-162. [acesso em 2015 June

Disponível em: http://eprints.gla.ac.uk/8107/1/id8107.pdf

Dear JW, Webb DJ. Disease mongering -- a challenge for everyone involved in healthcare. Br J Clin Pharmacol. 2007;64(2):122-124. http://dx.doi.org/10.1111/j.1365-2125.2006.02830.x. PMid:17214830. DOI: https://doi.org/10.1111/j.1365-2125.2006.02830.x

Gérvas J, Pérez-Fernández MP. Sano y Salvo y libre de intervenciones médicas innecesarias. Barcelona; Los Libros del Lince; 2013.

St-Onge JC. Tous fous? Montreal: Écosociété; 2013.

Goroll AH, May LA, Mulley AG, editores. Prymare care medicine. Philadelphia: JB Lippincott; 1995.

Weiss BD, editor. 20 commom problems in primary care. San Antonio: McGraw-Hill; 1999. p. 79-120.

Oliveira JEP, Vencio S, editors Diretrizes da sociedade brasileira de diabetes. São Paulo: AC Farmacêutica; 2015. 116 p.

Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014;174(8):1227-1234. http://dx.doi.org/10.1001/jamainternmed.2014.2894. PMid:24979148. DOI: https://doi.org/10.1001/jamainternmed.2014.2894

Jamoulle M, Berstein J, Pizzanelli Baez M, Silva A, Wagner H. Prévention quaternaire: un concept fondé sur le temps et la relation. Deuxième partie. L’étonnante diffusion internationale du concept. Médecine. 2014(10)2:75-77. http://dx.doi.org/10.1684/med.2014.1066.

Jamoulle M. Quaternary prevention, an answer of family doctors to overmedicalization. Intern J Health Policy Manag. 2015;4(2).61-64. http://dx.doi.org/10.15171/ijhpm.2015.24. DOI: https://doi.org/10.15171/ijhpm.2015.24